VU LSC-EMBL Partnership for Genome Editing Technologies
4.8 (464) · € 14.00 · En Stock
EMBL and VU LSC, recognising the scientific and technological potential of uniting their complementary strengths in the field of targeted genome modification, decided to intensify existing links and build further institutional synergies by creating the Partnership for Genome Editing Technologies.
Partnerships
The Partnership Institute of the European Molecular Biology Laboratory to Open at VU LSC
Genetically encoded phosphatidylserine biosensor for in vitro, ex vivo and in vivo labelling, Cellular & Molecular Biology Letters
VU Life Sciences Center on LinkedIn: #research #researchers #science #crispr #jobopportunity
Lina Malinauskaite - Principal Investigator - VU Life Sciences Center
Genetically encoded phosphatidylserine biosensor for in vitro, ex vivo and in vivo labelling, Cellular & Molecular Biology Letters
VU Gyvybės mokslų centras - To develop novel genome editing technologies and tools VU LSC-EMBL Partnership Institute is looking for already 6 researches. They would work in research groups/laboratories led by Dr
CRISPR-Cas Tools and Technologies
Molecular insights into intra-complex signal transmission during stressosome activation
